CompoAtlas

SOMMEIL MELATONINE 1 mg

Food supplement declared in France, declaration No 2021-7-389

SOMMEIL MELATONINE 1 mg is a food supplement declared in France. Status: retiré du marché le 30 August 2026. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
DAYANG
Status
Retiré du marché le 30 August 2026
Form
Comprimé
Daily dose
1 comprimé
Directions for use
Prendre 1 comprimé avec un verre d'eau (150 ml) 30 minutes avant le coucher
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Nourrissons (moins de 1 an), Sous traitement médicamenteux, Utilisation prolongée
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil, Système nerveux

Declaration 304937, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Melissa officinalis L.Parties aériennesExtrait sec aqueux150 mg
Passiflora incarnata L.Parties aériennesExtrait sec aqueux150 mg
Valeriana officinalis L.RacineExtrait sec aqueux100 mg

Other active ingredients

NamePer day
Tryptophanenot declared
Mélatoninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Oxyde de magnésiumMagnésium250 mg300 mg
Chlorhydrate de pyridoxineVitamine B612 mg2 mg

Additives

E420, E470b, E468, E551

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes et allaitantes, aux enfants et adolescents. Déconseillé aux personnes souffrant de maladies inflammatoires ou auto-immunes, aux personnes devant réaliser une activité nécessitant une vigilance soutenue et pouvant poser un problème de sécurité en cas de somnolence. Les personnes épileptiques, asthmatiques, souffrant de troubles de l'humeur, du comportement ou de la personnalité ; ou suivant un traitement médicamenteux, doivent consulter un médecin avant consommation de ce produit. Limiter la prise du complément alimentaire à un usage ponctuel. Une consommation excessive peut avoir des effets laxatifs.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line